Page last updated: 2024-08-25

methotrexate and 2019 Novel Coronavirus Disease

methotrexate has been researched along with 2019 Novel Coronavirus Disease in 93 studies

Research

Studies (93)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	93 (100.00)	2.80

Authors

Authors	Studies
Gowda, P; Joshi, SD; Kumawat, RK; Patrick, S; Sen, E	1
Dimopoulou, D; Maritsi, DN; Spyridis, N; Tsolia, MN; Vartzelis, G	1
Amoura, Z; Anna, F; Boutin, THD; Breillat, P; Chaieb, H; Charneau, P; Cohen-Aubart, F; de Alba, S; Flores, PM; Ghillani-Dalbin, P; Gorochov, G; Haroche, J; Lhote, R; Mathian, A; Miyara, M; Moyon, Q; Mudumba, S; Pha, M; Sterlin, D	1
Bogacheva, M; Gawriyski, L; Hassinen, A; Huuskonen, S; Keskitalo, S; Laitinen, T; Liu, X; Öhman, T; Pietiäinen, V; Pöhner, I; Poso, A; Redchuk, T; Salokas, K; Tonduru, AK; Varjosalo, M; Vartiainen, MK	1
Alidoust, F; Bahmani, K; Ebrahimi-Dehkordi, S; Faraji Dana, H; Ganjei, Z	1
Argyropoulou, OD; Bakasis, AD; Bitzogli, K; Chatzis, LG; Cinoku, II; Fotiadis, DI; Gazi, S; Georgountzos, AI; Goules, AV; Katechis, S; Katsifis, G; Katsimpari, C; Liossis, SN; Mavrommati, M; Moutsopoulos, HM; Papagoras, C; Pezoulas, V; Sfontouris, CI; Skopouli, FN; Stergiou, IE; Tzioufas, AG; Venetsanopoulou, AI; Vlachoyiannopoulos, PG; Voulgari, PV	1
Haas, JP; Hügle, B; Krumrey-Langkammerer, M	1
Cerna, K; Duricova, D; Hruba, V; Kastylova, K; Kostrejova, M; Kubickova, K; Lukas, M; Machkova, N; Mitrova, K; Teplan, V; Vasatko, M	1
Classen, JM; Ebigbo, A; Fleischmann, C; Messmann, H; Muzalyova, A; Nagl, S; Römmele, C; Schnoy, E	1
Bruel, T; Buffier, S; Casadevall, M; Chatenoud, L; Delage, L; Ermak, N; Hadjadj, J; Henriquez, S; Macraigne, L; Morbieu, C; Mouthon, L; Nguyen, Y; Ouedrani, A; Péré, H; Planas, D; Rieux-Laucat, F; Schwartz, O; Staropoli, I; Stolzenberg, MC; Terrier, B; Veyer, D	1
Aikawa, NE; Araujo, CSR; Balbi, GGM; Bonfa, E; Bonfiglioli, KR; da Silva, HC; Domiciano, DS; Kallas, EG; Kupa, LVK; Medeiros-Ribeiro, AC; Nakai, TL; Pasoto, SG; Pedrosa, T; Saad, CGS; Shimabuco, AY; Silva, CA; Silva, MSR; Yuki, EFN	1
Benoy, S; Broen, J; den Broeder, AA; Lamers-Karnebeek, F; Opdam, MAA; Traksel, RAM; Van Bijnen, S; Verhoef, LM; Vos, P	1
Aikawa, NE; Araujo, CSR; Bonfa, E; Bonfiglioli, KR; Domiciano, DS; Kupa, LVK; Medeiros-Ribeiro, AC; Pasoto, SG; Pedrosa, T; Pereira, RMR; Saad, CGS; Shimabuco, AY; Silva, CA; Silva, MSR; Yuki, EFN; Zou, G	1
Cadena, J; Chan, KHR; Gryshuk, AL; Hong, JC; Huang, FW; Kwon, DH; Nguyen, S; Ray, P; Soper, B	1
Albach, FN; Arumahandi de Silva, AN; Biesen, R; Burmester, GR; Corman, VM; Drosten, C; Frommert, LM; Jeworowski, LM; Klotsche, J; Scholz, V; Schwarz, T; Ten Hagen, A; Zernicke, J	1
Akashi, K; Arinobu, Y; Ayano, M; Hiura, J; Horiuchi, T; Hotta, T; Irino, K; Kang, D; Kashiwado, Y; Kawano, S; Kimoto, Y; Mitoma, H; Nakano, S; Niiro, H; Ohshima, S; Ono, N; Sawabe, T; Takeuchi, T; Wang, Q	1
Eder, A; Feuchtenberger, M; Kovacs, MS; Nigg, A; Schäfer, A	2
Abe, M; Harigai, M; Ikari, K; Inoue, E; Ochiai, M; Saka, K; Sugano, E; Tanaka, E; Yamaguchi, R; Yamanaka, H	1
Dobashi, H; Inoo, M; Kadowaki, N; Kameda, T; Kato, M; Mino, R; Miyagi, T; Mizusaki, M; Nakashima, S; Nomura, Y; Shimada, H; Sugihara, K; Wakiya, R	1
Auroux, M; Confavreux, CB; Coste, B; Coury, F; Durieu, I; Laurent, B; Lega, JC; Mainbourg, S; Massy, E; Mercier, A	1
Abhishek, A; Altmann, DM; Appelbe, D; Barber, VS; Bluett, J; Boyton, RJ; Coates, L; Cook, JA; Cureton, L; Eldridge, L; Francis, A; Julier, P; McKnight, Á; Nguyen-Van-Tam, J; Peckham, N; Rombach, I; Valdes, AM; Williams, HC	1
Colhoun, HM; Hollick, RJ; McAllister, DA; McKeigue, PM; Porter, D; Ralston, SH	1
Altınay, S; Kural, A; Özmen, A; Tural, D; Tutar, Y	1
Akinde, M; Amy de la Bretêque, M; Bachelerie, M; Bachelez, H; Beauchet, A; Bellissen, A; Belloni Fortina, A; Bourrat, E; Brzezinski, P; Bursztejn, AC; Chiriac, A; Di Lernia, V; Epishev, R; Flohr, C; Lasek, A; Lesiak, A; Luca, C; Luna, PC; Mahé, E; Mahil, SK; Mallet, S; Maruani, A; McPherson, T; Murashkin, N; Neri, I; Smith, CH; Sonkoly, E; Steff, M; Thomas, J; Topkarci, Z; Torres, T; van den Reek, JMPA; Vidaurri de la Cruz, H; Zafiriou, E; Zitouni, J	1
Ahmed, S; Benny, J; Cherian, S; Mehta, P; Panthak, A; Paul, A; Shenoy, P	1
Alonso, C; Bertoli, A; Cogo, AK; Cosatti, MA; Cosentino, V; de la Vega, MC; De Los Ángeles Correa, M; de Los Ángeles Severina, M; Echeverría, C; Elkin, MSG; Exeni, MED; García, L; Isnardi, CA; Kogan, N; Kreimer, JL; Landi, M; Luna, PC; Mussano, E; Nieto, RE; Pereira, D; Petkovic, I; Pisoni, CN; Pons-Estel, GJ; Quintana, R; Retamozo, C; Roberts, K; Rosemffet, M; Savio, VG; Schneeberger, EE; Tissera, Y; Virasoro, BM; Zelaya, MD	1
Sparks, JA; Tedeschi, SK	1
Abhishek, A; Altmann, DM; Appelbe, D; Barber, V; Bluett, J; Boyton, RJ; Brooks, T; Coates, LC; Cook, JA; Cureton, L; Eldridge, L; Francis, A; Julier, P; McKnight, Á; Nguyen-Van-Tam, JS; Peckham, N; Rombach, I; Valdes, AM; Williams, HC	1
Dimopoulou, D; Maritsi, DN; Spyridis, N; Tsolia, MN	1
Broyde, A; Elalouf, O; Elias, M; Elkayam, O; Eviatar, T; Feld, J; Freund, T; Furer, V; Gazitt, T; Gertel, S; Haddad, A; Hagin, D; Higazi, N; Kaufman, I; Kharouf, F; Levartovsky, D; Nevo, S; Paran, D; Pel, S; Peleg, H; Polachek, A; Zisman, D	1
Alcobendas Rueda, R; Calvo, C; Cámara, C; Díaz Almirón, M; Díaz-Delgado, B; Falces-Romero, I; Méndez-Echevarría, A; Miguel Berenguel, L; Millán Longo, C; Muñoz Gómez, C; Ochando, J; Remesal Camba, A; Udaondo, C	1
Gaffo, AL; Green, R; Merriman, T; Morgan, SL; Robinson, P; Topless, R	1
Jorda, A; Zeitlinger, M	1
Andreica, I; Anft, M; Babel, N; Baraliakos, X; Blazquez-Navarro, A; Kiltz, U; Pfaender, S; Sokolar, J; Stervbo, U; Vidal Blanco, E; Westhoff, T	1
Aikawa, NE; Bonfa, E; C B Moraes, J; F N Yuki, E; G Pasoto, S; G S Saad, C; G Schainberg, C; Gonçalves, CR; K Aoyama, R; Medeiros-Ribeiro, AC; S R Araujo, C; S R Silva, M; Sampaio-Barros, PD; Shimabuco, AY; Silva, CA; V K Kupa, L	1
Bonino, L; Calandra, V; Franchi, MP; Musizzano, Y; Olearo, E; Orcioni, GF; Puppo, A; Uccella, S	1
McHugh, J	1
Brück, C; Di Cristanziano, V; Esser, RL; Kofler, DM; Stahl, D; Thiele, J; Tho Pesch, C	1
Ahmadov, E; Albach, FN; Arumahandi de Silva, AN; Biesen, R; Burmester, GR; Frommert, LM; Gieselmann, L; Habermann, E; Klein, F; Klotsche, J; Kurth, F; Sander, LE; Ten Hagen, A; Tober-Lau, P; Zernicke, J	1
Alharbi, SO	1
Chen, L; Li, HJ; Lin, SP; Zheng, YQ	1
Kawali, A; Mahendradas, P; Sanjay, S; Shetty, R; Singh, Y; Yathish, GC	1
Barrett, R; Culliford, D; Edwards, CJ; Fraser, S; Lin, SX	1
Chang, TY; Chang, YH; Chen, YC; Chen, YT; Chin, YF; Chu, JW; Hsieh, PS; Hsu, HL; Hsu, NY; Hsu, SC; Hsu, YC; Huang, CH; Huang, YW; Hung, YJ; Lee, CY; Lee, JY; Li, TN; Lin, CH; Lin, WC; Liu, PC; Liu, YC; Luo, YC; Pathak, N; Tsai, HP; Tzou, SC; Wang, JY; Wang, LH; Wu Lee, YH; Wu, HL; Yang, CM; Yang, HJ; Yang, JM	1
Al-Janabi, A; Chinoy, H; Foulkes, AC; Griffiths, CEM; Hunter, HJA; Hyrich, KL; Limdi, JK; Littlewood, Z; Moriarty, CA; Ra, A; Warren, RB; Yiu, ZZN	1
Al-Sofi, RF; Armenteros, JJA; Bundgaard, H; Fogh, K; Frikke-Schmidt, R; Garred, P; Hamm, SR; Hansen, CB; Hasselbalch, RB; Heftdal, LD; Hilsted, L; Iversen, K; Kvist-Hansen, A; Madsen, JR; Møller, DL; Nielsen, SD; Ostrowski, SR; Pérez-Alós, L; Pries-Heje, MM; Skov, L; Sørensen, E; Zachariae, C	1
Borawska, A; Dabrowska-Iwanicka, A; Domanska-Czyz, K; Druzd-Sitek, A; Konecki, R; Kotarska, M; Lapinska, G; Michalski, W; Mroz-Zycinska, E; Osiadacz, W; Osowiecki, M; Ostrowska, B; Paszkiewicz-Kozik, E; Poplawska, L; Romejko-Jarosinska, J; Rymkiewicz, G; Swierkowska, M; Szymanski, M; Tajer, J; Targonski, L; Walewski, J; Wojciechowska-Lampka, E; Wojewodzka-Mirocha, M	1
Cahn, RT; Kolodney, MS; Zinn, Z	1
Becker, JC; Dittmer, U; Fiedler, M; Hölsken, S; Krefting, F; Lodde, GC; Placke, JM; Schadendorf, D; Schneider, L; Sondermann, W; Ugurel, S	1
Chan, A; Ciurea, SO; Doh, J; Griffin, SP; Jeyakumar, D; Kongtim, P; Lee, BJ; O'Brien, S	1
Akhavan-Sigari, R; Al-Haideri, MT; Alimohammadi, M; Cotrina-Aliaga, JC; Darvishi, M; Darvishzadehdeldari, S; Faramarzi, F; Gharebakhshi, F; Kaboli, R; Khorasani, S; Mannani, R; Tahmasebi, S	1
Adiay, C; Akin Cakici, O; Apti Sengun, O; Ay, P; Enul, H; Ergun, T; Haklar, G; Hosgoren Tekin, S; Seckin, D; Sili, U; Yilmaz, S	1
Ciechomska, M; Kuca-Warnawin, E; Wroński, J	1
Verzero, M	1
Aazami, H; Kamali, M; Khoshmirsafa, M; Mansouri, D; Mohsenzadegan, M; Pornour, M; Seif, F	1
Biglia, A; Bozzalla Cassione, E; Cavagna, L; Codullo, V; Montecucco, C; Zanframundo, G	1
Durairaj, S; Khan, S	1
Nath, A; Safavi, F	1
Alvaro-Gracia, JM; Diaz-Torne, C; Gomez-Reino, J; Gonzalez-Gay, MA; Manero, J; Pego-Reigosa, JM; Rúa-Figueroa, Í; Sanchez-Piedra, C	1
Jindal, A; Noronha, M; Pai, K; Pai, S; Ramesh, S	1
Garg, PK; Kaul, P; Pasricha, R; Singh, MP	1
Lange, U; Müller-Ladner, U; Steinchen, N	1
Cruz, RA; Frohman, EM; Frohman, TC; Longmuir, R; Rowe, ES; Rowe, V; Steinman, L; Varkey, TC; Villemarette-Pittman, NR; Zamvil, SS	1
Mansouri, D; Pornour, M; Seif, F	1
Bernar, B; Crazzolara, R; Griesmacher, A; Kapelari, K; Kropshofer, G; Müller, T; Scholl-Bürgi, S	1
Gasparyan, AY; Misra, DP; Zimba, O	1
Alberghina, L; Bonfanti, P; Bugatti, A; Caccuri, F; Caruso, A; Cazzaniga, ME; Messa, C; Perno, CF; Vanoni, M; Zani, A	1
Feldman, S; Gayam, S; Kolodney, M; Yousaf, A; Zinn, Z	1
Gangopadhyay, D; Radhakrishnan, V	1
Aguirre Portu, N; Aranda Alonso, Á; Calvo Galindo, R; Casas Deza, D; de Los Mozos Ruano, A; García López, S; Meriño Ibarra, EE; Solana Hidalgo, MP	1
Armesto, S; Gómez-Fernández, C; González López, MA; González Vela, C; González-Gay, MA; Illaro, A; López Sundh, AE; Mayorga, J; Naharro Fernández, C; Palmou, N; Sánchez, J	1
Imaduddin, M; Kar, M; Muduly, DK; Sultania, M; Vigneshwaran, B	1
Ahmadinejad, Z; Assari, R; Ayoobi Yazdi, N; Javanshayani, P; Khalili Afousi, H; Mazloomi, SH; Ziaee, V	1
Agarwal, A; B, S; Khurana, A; Muddebihal, A; Paliwal, P; Raina, A; Sardana, K; Saxena, S	1
Araujo Júnior, E; Elito Júnior, J	1
Bjornsson, AH; Grondal, G; Gudbjornsson, B; Jonsdottir, T; Kristjansson, M; Love, TJ	1
Cuckle, H; Dvash, S; Maymon, R; Padoa, A; Smorgick, N; Vaknin, Z	1
Dörks, M; Douros, A; Hoffmann, F; Jobski, K	1
Wu, HJ	1
Elledge, SJ; Fang, Y; Gentili, M; Gewurz, BE; Guo, R; Hung, DT; Kim, SH; Leary, CNO; Liang, JH; Mootha, VK; Shah, H; Zhang, S; Zhang, Y	1
Altincatal, A; Berdofe, A; Centonze, D; de Moor, C; Jung, E; Kim, M; Nagpal, A; Naylor, ML; Popescu, C; Radhakrishnan, M; Rajbhandari, R; Reder, AT; Sandrock, AW; Smirnakis, K	1
Cohen, AD; Damiani, G; Kridin, K; Peretz, A; Schonmann, Y; Tzur Bitan, D; Weinstein, O	1
Bierwirth, C; Dickmanns, A; Dobbelstein, M; Freund, J; Gerber, S; Görlich, D; Groß, U; Klemke, L; Lugert, R; Manzini, V; Meister, TL; Nikolova, V; Pfaender, S; Salinas, G; Schlösser, D; Sitte, M; Stegmann, KM; Wollnik, B	1
Bucci, L; Burmester, G; Caporali, R; Cobra, JF; Dürholz, K; Figuereido, C; Manger, B; Schälter, F; Schett, G; Zaiss, MM	1
Krüger, K	1
Albach, FN; Biesen, R; Burmester, GR	1
Baldanti, F; Balduzzi, S; Bogliolo, L; Bugatti, S; Cassaniti, I; D'Onofrio, B; De Stefano, L; di Lernia, M; Greco, MI; Lilleri, D; Luvaro, T; Manzo, A; Mauric, E; Mazzucchelli, I; Montecucco, C	1
Aylı, M; Caliskan, E; Coban, SN; Esme, P; Ugur, B	1
Bargagli, E; Bergantini, L; Cantarini, L; Conticini, E; d'Alessandro, M; Frediani, B; Gentili, F; Mazzei, MA	1
Demir, B; Demir, E; Sütcüoğlu, O; Ünsal, O; Yazıcı, O	1

Reviews

8 review(s) available for methotrexate and 2019 Novel Coronavirus Disease

Article	Year
Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: A cohort study and a meta-analysis. Joint bone spine, 2022, Volume: 89, Issue:5 Topics: Abatacept; Adult; Aged; Antirheumatic Agents; Cohort Studies; COVID-19; COVID-19 Vaccines; Humans; Immunoglobulin G; Leflunomide; Methotrexate; Observational Studies as Topic; Pandemics; Rheumatic Diseases; Rituximab; SARS-CoV-2; Seroepidemiologic Studies; Serotonin Agents; Spike Glycoprotein, Coronavirus; Vaccination	2022
Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind. Anti-cancer agents in medicinal chemistry, 2023, Volume: 23, Issue:3 Topics: COVID-19; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Meta-Analysis as Topic; Methotrexate; Neoplasm Recurrence, Local; SARS-CoV-2; Skin Neoplasms; Systematic Reviews as Topic; United States	2023
The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease: A systematic review of clinical evidence. Transplant immunology, 2023, Volume: 79 Topics: Antibodies, Viral; COVID-19; COVID-19 Vaccines; Humans; Immunity, Cellular; Immunoglobulin G; Immunomodulating Agents; Infant, Newborn; Methotrexate; Middle Aged	2023
Impact of methotrexate treatment on vaccines immunogenicity in adult rheumatological patients - Lessons learned from the COVID-19 pandemic. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 165 Topics: Adult; COVID-19; COVID-19 Vaccines; Humans; Influenza Vaccines; Methotrexate; Pandemics; Rheumatic Diseases; Rheumatology; Vaccination	2023
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19. International archives of allergy and immunology, 2020, Volume: 181, Issue:6 Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azetidines; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Janus Kinases; Methotrexate; Molecular Targeted Therapy; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Purines; Pyrazoles; Receptor, Angiotensin, Type 1; SARS-CoV-2; Signal Transduction; STAT Transcription Factors; Sulfonamides	2020
Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack. Journal of the neurological sciences, 2020, 08-15, Volume: 415 Topics: Betacoronavirus; Clinical Trial Protocols as Topic; Coronavirus Infections; COVID-19; Disease Management; Humans; Immunosuppressive Agents; Immunotherapy; Leucovorin; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates. Rheumatology international, 2020, Volume: 40, Issue:11 Topics: Antirheumatic Agents; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Hydroxychloroquine; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Methotrexate pneumonitis in a patient with Crohn's disease, during the COVID pandemic: An unusual clinical case and review of the literature. Gastroenterologia y hepatologia, 2021, Volume: 44, Issue:4 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; COVID-19; Crohn Disease; Female; Humans; Methotrexate; Middle Aged; Pneumonia	2021

Trials

4 trial(s) available for methotrexate and 2019 Novel Coronavirus Disease

Article	Year
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial. Annals of the rheumatic diseases, 2022, Volume: 81, Issue:6 Topics: Adult; Antibodies, Neutralizing; Antibodies, Viral; Arthritis, Rheumatoid; COVID-19; COVID-19 Vaccines; Humans; Immunoglobulin G; Methotrexate; Prospective Studies; SARS-CoV-2; Withholding Treatment	2022
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested m BMJ open, 2022, 05-03, Volume: 12, Issue:5 Topics: COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Humans; Methotrexate; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Vaccines	2022
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial. The Lancet. Respiratory medicine, 2022, Volume: 10, Issue:9 Topics: Adult; Arthritis, Rheumatoid; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Male; Methotrexate; Middle Aged; Prospective Studies; Psoriasis; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2022
Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis. Joint bone spine, 2023, Volume: 90, Issue:1 Topics: Antirheumatic Agents; Arthritis, Psoriatic; Axial Spondyloarthritis; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Methotrexate; Prednisone; Prospective Studies; SARS-CoV-2; Spondylarthritis; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha	2023

Other Studies

81 other study(ies) available for methotrexate and 2019 Novel Coronavirus Disease

Article	Year
Repurposing Methotrexate in Dampening SARS-CoV2-S1-Mediated IL6 Expression: Lessons Learnt from Lung Cancer. Inflammation, 2022, Volume: 45, Issue:1 Topics: A549 Cells; Adenocarcinoma of Lung; Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents; Cell Line, Tumor; COVID-19; COVID-19 Drug Treatment; Cytokine Receptor gp130; Folate Receptor 2; Glycyrrhizic Acid; HMGB1 Protein; Humans; Immunosuppressive Agents; Interleukin-6; Janus Kinase 1; Lung Neoplasms; Methotrexate; Phosphorylation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; STAT3 Transcription Factor	2022
Safety and tolerability of the COVID-19 messenger RNA vaccine in adolescents with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors. Arthritis & rheumatology (Hoboken, N.J.), 2022, Volume: 74, Issue:2 Topics: Adalimumab; Adolescent; Antirheumatic Agents; Arthralgia; Arthritis, Juvenile; BNT162 Vaccine; COVID-19; Disease Progression; Etanercept; Fatigue; Female; Headache; Humans; Injection Site Reaction; Male; Methotrexate; Myalgia; SARS-CoV-2; Tumor Necrosis Factor Inhibitors; Young Adult	2022
BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus. Annals of the rheumatic diseases, 2022, Volume: 81, Issue:4 Topics: Adult; Antibodies, Viral; Antirheumatic Agents; BNT162 Vaccine; COVID-19; Female; Humans; Immunity, Humoral; Immunogenicity, Vaccine; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prospective Studies; SARS-CoV-2; Severity of Illness Index	2022
SARS-CoV-2-host proteome interactions for antiviral drug discovery. Molecular systems biology, 2021, Volume: 17, Issue:11 Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Drug Repositioning; Host-Pathogen Interactions; Humans; Mass Spectrometry; Methotrexate; Proteome; Proteomics; SARS-CoV-2; Virus Replication	2021
Methotrexate as a safe immunosuppressive agent during the COVID-19 pandemic. International immunopharmacology, 2021, Volume: 101, Issue:Pt B Topics: Adolescent; Adult; COVID-19; COVID-19 Drug Treatment; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Pandemics; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Young Adult	2021
A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases. Journal of autoimmunity, 2021, Volume: 125 Topics: 2019-nCoV Vaccine mRNA-1273; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; Autoimmune Diseases; BNT162 Vaccine; COVID-19; Female; Greece; Hereditary Autoinflammatory Diseases; Humans; Immunoglobulin G; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prospective Studies; Rheumatic Diseases; Rituximab; SARS-CoV-2; Young Adult	2021
Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication. Pediatric rheumatology online journal, 2021, Nov-29, Volume: 19, Issue:1 Topics: Adolescent; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Juvenile; Azetidines; Blood Sedimentation; C-Reactive Protein; Child; COVID-19; Etanercept; Female; Humans; Male; Methotrexate; Purines; Pyrazoles; Remission Induction; SARS-CoV-2; Sulfonamides; Symptom Flare Up; Uveitis	2021
Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study. Inflammatory bowel diseases, 2022, 10-03, Volume: 28, Issue:10 Topics: Antibodies, Viral; Antibody Formation; BNT162 Vaccine; C-Reactive Protein; ChAdOx1 nCoV-19; COVID-19; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Leukocyte L1 Antigen Complex; Methotrexate; Prospective Studies; SARS-CoV-2; Tumor Necrosis Factor-alpha; Ustekinumab; Vaccination	2022
Antibody Response to SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease: Results of a Single-Center Cohort Study in a Tertiary Hospital in Germany. Digestive diseases (Basel, Switzerland), 2022, Volume: 40, Issue:6 Topics: Aged; Antibody Formation; Azathioprine; Cohort Studies; COVID-19; COVID-19 Vaccines; Crohn Disease; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Inflammatory Bowel Diseases; Integrins; Male; Methotrexate; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers; Tumor Necrosis Factor-alpha	2022
Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases. Annals of the rheumatic diseases, 2022, Volume: 81, Issue:5 Topics: Antibodies, Viral; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Immunocompromised Host; Immunogenicity, Vaccine; Methotrexate; Prospective Studies; Rituximab; SARS-CoV-2	2022
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Annals of the rheumatic diseases, 2022, Volume: 81, Issue:5 Topics: Abatacept; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; COVID-19; COVID-19 Vaccines; Drug Therapy, Combination; Humans; Immunoglobulin G; Methotrexate; Middle Aged; Prospective Studies; SARS-CoV-2; Treatment Outcome; Vaccines, Inactivated	2022
Identification of Risk Factors for COVID-19 Hospitalization in Patients With Anti-Rheumatic Drugs: Results From a Multicenter Nested Case Control Study. Clinical pharmacology and therapeutics, 2022, Volume: 111, Issue:5 Topics: Aged; Antirheumatic Agents; Case-Control Studies; COVID-19; Hospitalization; Humans; Methotrexate; Rheumatic Diseases; Risk Factors	2022
COVID-19 outcomes in patients with cancer: Findings from the University of California health system database. Cancer medicine, 2022, Volume: 11, Issue:11 Topics: Adult; COVID-19; COVID-19 Testing; Hospitalization; Humans; Methotrexate; Neoplasms; Retrospective Studies; SARS-CoV-2	2022
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases. Annals of the rheumatic diseases, 2022, Volume: 81, Issue:6 Topics: Aged; Antibodies, Viral; Autoimmune Diseases; COVID-19; COVID-19 Vaccines; Humans; Immunogenicity, Vaccine; Methotrexate; Middle Aged; Retrospective Studies; Rheumatic Diseases; SARS-CoV-2; Vaccination	2022
Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study. Modern rheumatology, 2023, Mar-02, Volume: 33, Issue:2 Topics: Abatacept; Antibody Formation; Calcineurin Inhibitors; Cohort Studies; COVID-19; COVID-19 Vaccines; Cyclophosphamide; Humans; Immunosuppressive Agents; Japan; Methotrexate; Mycophenolic Acid; Prospective Studies; Rheumatic Diseases; Rituximab; SARS-CoV-2; Tumor Necrosis Factor Inhibitors	2023
Methotrexate significantly reduces the humoral vaccination response against SARS-CoV-2 in older but not younger patients with rheumatoid arthritis. Rheumatology international, 2022, Volume: 42, Issue:6 Topics: Aged; Antibodies, Neutralizing; Antibodies, Viral; Arthritis, Rheumatoid; COVID-19; Cross-Sectional Studies; Humans; Methotrexate; Middle Aged; SARS-CoV-2; Vaccination	2022
Changes in treatment adherence and behaviour during the COVID-19 pandemic in Japanese patients with rheumatoid arthritis: Results from cross-sectional study in the IORRA cohort. Modern rheumatology, 2022, 10-15, Volume: 32, Issue:6 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; COVID-19; Cross-Sectional Studies; Humans; Japan; Methotrexate; Pandemics; Treatment Adherence and Compliance	2022
Immunogenicity against the BNT162b2 mRNA COVID-19 Vaccine in Rheumatic Disease Patients Receiving Immunosuppressive Therapy. Internal medicine (Tokyo, Japan), 2022, Jul-01, Volume: 61, Issue:13 Topics: Antibodies, Viral; BNT162 Vaccine; COVID-19; Humans; Immunogenicity, Vaccine; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; Neutralization Tests; Rheumatic Diseases; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2022
Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland. Scandinavian journal of rheumatology, 2023, Volume: 52, Issue:4 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Case-Control Studies; COVID-19; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; Prednisolone; Rheumatic Diseases	2023
Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry). Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:11 Topics: Adolescent; Adult; Biological Factors; Biological Products; Child; COVID-19; Disease Progression; Humans; Methotrexate; Pandemics; Psoriasis; Registries	2022
Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease. Clinical rheumatology, 2022, Volume: 41, Issue:11 Topics: Autoimmune Diseases; ChAdOx1 nCoV-19; COVID-19; COVID-19 Vaccines; Humans; Methotrexate; Mycophenolic Acid; Rheumatic Diseases; Sulfasalazine; Vaccines	2022
An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data. Clinical rheumatology, 2022, Volume: 41, Issue:10 Topics: Adult; Aged; Antirheumatic Agents; Argentina; ChAdOx1 nCoV-19; COVID-19; COVID-19 Vaccines; Female; Glucocorticoids; Humans; Janus Kinase Inhibitors; Male; Methotrexate; Middle Aged; Preliminary Data; Registries; RNA, Messenger; SARS-CoV-2; Vaccination; Vaccines, Inactivated	2022
Improving COVID-19 vaccine immunogenicity by interrupting methotrexate treatment. The Lancet. Respiratory medicine, 2022, Volume: 10, Issue:9 Topics: COVID-19; COVID-19 Vaccines; Humans; Immunogenicity, Vaccine; Immunosuppressive Agents; Methotrexate	2022
Immunogenicity 6 months post COVID-19 mRNA vaccination among adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors. Rheumatology (Oxford, England), 2023, 02-23, Volume: 62, Issue:SI2 Topics: Adolescent; Arthritis, Juvenile; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Immunogenicity, Vaccine; Methotrexate; Pandemics; RNA, Messenger; SARS-CoV-2; Tumor Necrosis Factor Inhibitors; Vaccination	2023
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre study. Annals of the rheumatic diseases, 2022, Volume: 81, Issue:11 Topics: Abatacept; Adult; Antibodies, Viral; Antirheumatic Agents; Autoimmune Diseases; BNT162 Vaccine; COVID-19; Humans; Immunogenicity, Vaccine; Immunoglobulin G; Janus Kinases; Methotrexate; Prospective Studies; Rheumatic Diseases; Rituximab	2022
Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases. Pediatric rheumatology online journal, 2022, Aug-13, Volume: 20, Issue:1 Topics: Adolescent; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Immunity, Cellular; Interleukin-2; Methotrexate; Rheumatic Diseases; RNA, Messenger; SARS-CoV-2; Tumor Necrosis Factor Inhibitors; Viral Vaccines	2022
Janus kinase (JAK) inhibitors significantly reduce the humoral vaccination response against SARS-CoV-2 in patients with rheumatoid arthritis. Clinical rheumatology, 2022, Volume: 41, Issue:12 Topics: Antibodies, Neutralizing; Antibodies, Viral; Antirheumatic Agents; Arthritis, Rheumatoid; COVID-19; Cross-Sectional Studies; Humans; Janus Kinase Inhibitors; Janus Kinases; Methotrexate; SARS-CoV-2; Vaccination	2022
Folic acid and methotrexate use and their association with COVID-19 diagnosis and mortality: a case-control analysis from the UK Biobank. BMJ open, 2022, 08-24, Volume: 12, Issue:8 Topics: Biological Specimen Banks; Case-Control Studies; COVID-19; COVID-19 Testing; Folic Acid; Humans; Methotrexate; SARS-CoV-2; United Kingdom	2022
Interrupting methotrexate to improve immunity after COVID-19 booster vaccination: is it really worth it? The Lancet. Respiratory medicine, 2022, Volume: 10, Issue:9 Topics: COVID-19; Enzyme-Linked Immunosorbent Assay; Humans; Methotrexate; Vaccination	2022
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination. RMD open, 2022, Volume: 8, Issue:2 Topics: Antibodies, Neutralizing; Antirheumatic Agents; Arthritis, Rheumatoid; COVID-19; COVID-19 Vaccines; Female; Humans; Immunoglobulin G; Janus Kinase Inhibitors; Male; Methotrexate; Middle Aged; SARS-CoV-2; Vaccination	2022
Successful laparoscopic surgical removal of a caesarean scar pregnancy (CSP) using temporary uterine artery ligation. Journal of minimally invasive gynecology, 2022, Volume: 29, Issue:12 Topics: Cesarean Section; Chorionic Gonadotropin, beta Subunit, Human; Cicatrix; COVID-19; Female; Humans; Laparoscopy; Methotrexate; Pregnancy; Pregnancy, Ectopic; Retrospective Studies; Treatment Outcome; Uterine Artery	2022
Optimizing methotrexate withdrawal during COVID vaccination. Nature reviews. Rheumatology, 2022, Volume: 18, Issue:11 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; COVID-19; Humans; Methotrexate; Vaccination	2022
Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritis. RMD open, 2022, Volume: 8, Issue:2 Topics: Aged; Antibodies, Viral; Arthritis, Rheumatoid; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Immunity, Humoral; Immunoglobulin G; Methotrexate; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2022
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination. RMD open, 2022, Volume: 8, Issue:2 Topics: Antirheumatic Agents; COVID-19; COVID-19 Vaccines; Humans; Methotrexate; SARS-CoV-2; Vaccination; Vaccines	2022
COVID-19 in a patient with new adult-onset Still disease: A case report. Medicine, 2022, Oct-07, Volume: 101, Issue:40 Topics: Adrenal Cortex Hormones; Adult; Arthritis; Biomarkers; COVID-19; Exanthema; Female; Ferritins; Fever; Humans; Methotrexate; Still's Disease, Adult-Onset	2022
Effect of interrupting methotrexate treatment on COVID-19 booster vaccine response. Drug and therapeutics bulletin, 2022, Volume: 60, Issue:11 Topics: Adult; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Humans; Methotrexate; Randomized Controlled Trials as Topic	2022
Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases. Scientific reports, 2022, 10-26, Volume: 12, Issue:1 Topics: Antibodies, Viral; Autoimmune Diseases; COVID-19; COVID-19 Vaccines; Humans; Hydroxychloroquine; Immunogenicity, Vaccine; Immunoglobulin G; Lupus Erythematosus, Systemic; Methotrexate; Rheumatic Diseases; Rheumatic Fever; Rituximab	2022
COVID-19 vaccination and recurrent anterior uveitis. Indian journal of ophthalmology, 2022, Volume: 70, Issue:12 Topics: Acute Disease; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Inflammation; Methotrexate; SARS-CoV-2; Uveitis, Anterior; Vaccination	2022
Impact of the COVID-19 pandemic on prescription refills for immune-mediated inflammatory disorders: a time series analysis (January 2019 to January 2021) using the English Prescribing Dataset. BMJ open, 2022, 12-23, Volume: 12, Issue:12 Topics: Azathioprine; Communicable Disease Control; COVID-19; Drug Prescriptions; Humans; Hydroxychloroquine; Leflunomide; Methotrexate; Pandemics; Sulfasalazine; Time Factors	2022
Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation revealed by bioinformatics approach and a hamster model. Frontiers in immunology, 2022, Volume: 13 Topics: Animals; Antiviral Agents; Computational Biology; COVID-19; Cricetinae; Inflammation; Methotrexate; SARS-CoV-2	2022
The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study. The British journal of dermatology, 2023, 03-30, Volume: 188, Issue:4 Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Antibodies, Viral; BNT162 Vaccine; ChAdOx1 nCoV-19; COVID-19; COVID-19 Vaccines; Humans; Immunologic Factors; Immunomodulating Agents; Methotrexate; Middle Aged; Prospective Studies; Rituximab; Vaccines; Young Adult	2023
Waning humoral and cellular immunity after COVID-19 vaccination in patients with psoriasis treated with methotrexate and biologics: a cohort study. The British journal of dermatology, 2023, 04-20, Volume: 188, Issue:5 Topics: Antibodies, Viral; Biological Products; Cohort Studies; COVID-19; COVID-19 Vaccines; Humans; Immunity, Cellular; Methotrexate; Prospective Studies; Psoriasis; SARS-CoV-2; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Vaccination	2023
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (R-MIV) in patients with primary CNS lymphoma including recent COVID-19 pandemic experience. British journal of haematology, 2023, Volume: 201, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; COVID-19; Cytarabine; Humans; Ifosfamide; Lymphoma; Methotrexate; Pandemics; Prospective Studies; Rituximab; SARS-CoV-2; Vincristine	2023
Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of "Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate". Journal of the American Academy of Dermatology, 2023, Volume: 88, Issue:6 Topics: COVID-19; Follow-Up Studies; Hospitalization; Humans; Methotrexate; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha	2023
COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study. Frontiers in immunology, 2023, Volume: 14 Topics: Antibodies, Viral; Cohort Studies; COVID-19; COVID-19 Vaccines; Humans; Immunoglobulin G; Methotrexate; Middle Aged; Prospective Studies; Psoriasis; Tumor Necrosis Factor-alpha	2023
Immunity 6 months after COVID-19 vaccination in patients with psoriasis treated with immunomodulatory drugs. The British journal of dermatology, 2023, 04-20, Volume: 188, Issue:5 Topics: Biological Products; Cohort Studies; COVID-19; COVID-19 Vaccines; Humans; Immunity, Cellular; Immunomodulating Agents; Methotrexate; Psoriasis; Vaccination	2023
Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice change. European journal of haematology, 2023, Volume: 111, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; COVID-19; Cyclophosphamide; Humans; Methotrexate; Pandemics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Vincristine	2023
Immunogenicity, efficacy, and safety of CoronaVac and Pfizer/BioNTech mRNA vaccines in patients with psoriasis receiving systemic therapies: A prospective cohort study. Vaccine, 2023, 06-29, Volume: 41, Issue:29 Topics: Antibodies, Neutralizing; Antibodies, Viral; Biological Factors; COVID-19; COVID-19 Vaccines; Drug-Related Side Effects and Adverse Reactions; Humans; Immunogenicity, Vaccine; Infliximab; Methotrexate; Prospective Studies; Psoriasis; SARS-CoV-2; Vaccines, Inactivated	2023
Empathy as the axis of care. Rethinking Comprehensive Health Care Policies and Practices with a Gender Perspective Vertex (Buenos Aires, Argentina), 2023, 07-10, Volume: 34, Issue:160, abr.- Topics: Cisplatin; COVID-19; Empathy; Humans; Methotrexate; Policy; Retrospective Studies	2023
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine. Annals of the rheumatic diseases, 2020, Volume: 79, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Cyclosporine; Diarrhea; Dysgeusia; Dyspnea; Fatigue; Female; Fever; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Incidence; Intensive Care Units; Italy; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Respiratory Distress Syndrome; SARS-CoV-2; Telemedicine	2020
JAK Inhibition with Methotrexate as Treatment for COVID-19 Is a Double-Edged Sword. International archives of allergy and immunology, 2020, Volume: 181, Issue:7 Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Silencing of immune activation with methotrexate in patients with COVID-19. Journal of the neurological sciences, 2020, 08-15, Volume: 415 Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Immunosuppressive Agents; Inflammation; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies. Annals of the rheumatic diseases, 2020, Volume: 79, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Glucocorticoids; Hospitalization; Humans; Hydroxychloroquine; Intensive Care Units; Interleukin 1 Receptor Antagonist Protein; Janus Kinase Inhibitors; Male; Methotrexate; Middle Aged; Pandemics; Pneumonia, Viral; Rheumatic Diseases; Rituximab; SARS-CoV-2; Spain; Spondylarthropathies; Tumor Necrosis Factor Inhibitors	2020
Intramatricial methotrexate for treatment of resistant acrodermatitis continua of Hallopeau: An alternative in COVID-19. Dermatologic therapy, 2020, Volume: 33, Issue:4 Topics: Acrodermatitis; Administration, Topical; Adult; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; Dermatologic Agents; Dose-Response Relationship, Drug; Female; Humans; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2; Skin	2020
Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium. Oral oncology, 2020, Volume: 107 Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Methotrexate; Mouth Neoplasms; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
[Biological therapy after COVID-19 infection : No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy]. Zeitschrift fur Rheumatologie, 2020, Volume: 79, Issue:6 Topics: Antibodies, Viral; Arthritis, Rheumatoid; Betacoronavirus; Biological Therapy; Coronavirus Infections; COVID-19; Humans; Leflunomide; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tumor Necrosis Factor Inhibitors; Virus Activation	2020
Combination of JAKinibs with Methotrexate or Anti-Cytokine Biologics in Patients with Severe COVID-19. International archives of allergy and immunology, 2020, Volume: 181, Issue:8 Topics: Betacoronavirus; Biological Products; Coronavirus Infections; COVID-19; Humans; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
SARS-CoV-2 infection in a 7-year-old girl with pancytopenia during acute lymphocytic leukemia maintenance therapy. Pediatric blood & cancer, 2020, Volume: 67, Issue:11 Topics: Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antiviral Agents; Austria; Child; COVID-19; COVID-19 Drug Treatment; Female; Humans; Mercaptopurine; Methotrexate; Pancytopenia; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; SARS-CoV-2; Treatment Outcome	2020
Methotrexate inhibits SARS-CoV-2 virus replication "in vitro". Journal of medical virology, 2021, Volume: 93, Issue:3 Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; COVID-19; Methotrexate; Pandemics; RNA, Viral; SARS-CoV-2; Vero Cells; Virus Replication	2021
Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study. Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:1 Topics: Adult; Aged; Case-Control Studies; COVID-19; Female; Hospitalization; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Propensity Score; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor Inhibitors	2021
Repeat-positive SARS-CoV-2 in a child with cancer. Pediatric blood & cancer, 2021, Volume: 68, Issue:3 Topics: Antimetabolites, Antineoplastic; Asymptomatic Diseases; Child, Preschool; COVID-19; Humans; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; SARS-CoV-2	2021
Treating multidrug-resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID-19 pandemic. Dermatologic therapy, 2020, Volume: 33, Issue:6 Topics: Adult; Antibodies, Monoclonal, Humanized; COVID-19; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Methotrexate; Prednisone; Psoriasis; SARS-CoV-2; Thalidomide	2020
Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic. Oral oncology, 2021, Volume: 114 Topics: Carcinoma; Celecoxib; Cisplatin; COVID-19; Humans; Methotrexate; Mouth Neoplasms; Neoplasm Recurrence, Local; Pandemics; SARS-CoV-2	2021
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with? Reumatismo, 2020, Nov-19, Volume: 72, Issue:3 Topics: Adalimumab; Adult; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Azathioprine; Betacoronavirus; Biological Therapy; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Drug Combinations; Drug Therapy, Combination; Humans; Lopinavir; Male; Methotrexate; Oseltamivir; Pandemics; Pneumonia, Viral; Prednisolone; Ritonavir; SARS-CoV-2	2020
Severe type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 103 Topics: Adrenal Cortex Hormones; Adult; COVID-19; COVID-19 Drug Treatment; Erythema Nodosum; Humans; Immunosuppressive Agents; Leprosy, Lepromatous; Male; Methotrexate; SARS-CoV-2	2021
Medical Treatment for Ectopic Pregnancy during the COVID-19 Pandemic. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2020, Volume: 42, Issue:12 Topics: Abortifacient Agents, Nonsteroidal; COVID-19; Female; Humans; Methotrexate; Patient Education as Topic; Patient Selection; Pregnancy; Pregnancy, Ectopic; SARS-CoV-2; Watchful Waiting	2020
Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland. Annals of the rheumatic diseases, 2021, Volume: 80, Issue:5 Topics: Antirheumatic Agents; COVID-19; Hospitalization; Humans; Hypoxia; Iceland; Methotrexate; Prevalence; Rheumatic Diseases; SARS-CoV-2	2021
Increase rate of ruptured tubal ectopic pregnancy during the COVID-19 pandemic. European journal of obstetrics, gynecology, and reproductive biology, 2021, Volume: 259 Topics: Abdominal Pain; Abortifacient Agents, Nonsteroidal; Adult; Chorionic Gonadotropin, beta Subunit, Human; Cohort Studies; COVID-19; Delayed Diagnosis; Female; Humans; Israel; Laparoscopy; Methotrexate; Pregnancy; Pregnancy, Tubal; Reproductive Techniques, Assisted; Retrospective Studies; Rupture, Spontaneous; Salpingectomy; SARS-CoV-2; Ultrasonography, Prenatal; Uterine Hemorrhage	2021
Global COVID-19 pandemic and reporting behavior - An analysis of the Food and Drug Administration adverse events reporting system. Pharmacoepidemiology and drug safety, 2021, Volume: 30, Issue:6 Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Canada; Child; Child, Preschool; COVID-19; COVID-19 Drug Treatment; Databases, Factual; Female; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Male; Methotrexate; Middle Aged; United States; United States Food and Drug Administration; Young Adult	2021
Methotrexate works remotely, from the gut. Cell host & microbe, 2021, 03-10, Volume: 29, Issue:3 Topics: Bacteria; COVID-19; Gastrointestinal Microbiome; Humans; Methotrexate; SARS-CoV-2	2021
SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication. Nature communications, 2021, 03-15, Volume: 12, Issue:1 Topics: A549 Cells; Animals; Carbon; Chlorocebus aethiops; COVID-19; Cytopathogenic Effect, Viral; Folic Acid; Folic Acid Antagonists; Glucose; Humans; Methotrexate; RNA, Viral; SARS-CoV-2; Serine; Transcription, Genetic; Vero Cells; Viral Proteins; Virus Replication	2021
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies. CNS drugs, 2021, Volume: 35, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cladribine; Comorbidity; COVID-19; Crotonates; Cyclophosphamide; Cyclosporine; Databases, Factual; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Hospitalization; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Incidence; Interferon-beta; Logistic Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid; Natalizumab; Nitriles; Obesity; Risk Factors; Rituximab; SARS-CoV-2; Toluidines; United States; White People; Young Adult	2021
Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization and Mortality in Patients with Psoriasis: A Population-Based Study. American journal of clinical dermatology, 2021, Volume: 22, Issue:5 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Biological Products; Case-Control Studies; Child; Child, Preschool; Comorbidity; COVID-19; Female; Hospitalization; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Middle Aged; Psoriasis; Risk Factors; SARS-CoV-2; Young Adult	2021
The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models. Virus research, 2021, Volume: 302 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Cell Culture Techniques; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Folic Acid Antagonists; Humans; Methotrexate; RNA, Viral; SARS-CoV-2; Vero Cells; Virus Replication	2021
Does methotrexate influence COVID-19 infection? Case series and mechanistic data. Arthritis research & therapy, 2021, 06-10, Volume: 23, Issue:1 Topics: Animals; COVID-19; Humans; Methotrexate; Mice; RNA, Viral; SARS-CoV-2	2021
[Does methotrexate influence the efficacy of vaccination against SARS-CoV-2?] Zeitschrift fur Rheumatologie, 2021, Volume: 80, Issue:6 Topics: Antirheumatic Agents; COVID-19; COVID-19 Vaccines; Humans; Methotrexate; Rheumatic Diseases; SARS-CoV-2; Vaccination	2021
Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response. Annals of the rheumatic diseases, 2021, Volume: 80, Issue:10 Topics: Antibodies, Neutralizing; Antibodies, Viral; Antirheumatic Agents; Arthritis, Rheumatoid; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Heterocyclic Compounds, 3-Ring; Humans; Immunization, Secondary; Immunocompromised Host; Immunogenicity, Vaccine; Male; Methotrexate; Middle Aged; Polycythemia Vera; SARS-CoV-2; Vasculitis, Leukocytoclastic, Cutaneous	2021
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis. Annals of the rheumatic diseases, 2021, Volume: 80, Issue:12 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Female; Glucocorticoids; Humans; Immunogenicity, Vaccine; Male; Methotrexate; Middle Aged; SARS-CoV-2	2021
A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2021, Volume: 60, Issue:5 Topics: Acitretin; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Contraindications, Drug; COVID-19; Cyclosporine; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Nails; Pandemics; Photopheresis; Psoriasis; Quality of Life; SARS-CoV-2; Severity of Illness Index; Ultraviolet Therapy	2021
Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report. Journal of medical virology, 2021, Volume: 93, Issue:12 Topics: Aged; Autoimmunity; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Male; Methotrexate; Microscopic Polyangiitis; Recurrence; SARS-CoV-2	2021
A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022, Volume: 28, Issue:2 Topics: Amides; Antiviral Agents; Bone Neoplasms; Chemical and Drug Induced Liver Injury; COVID-19; Humans; Methotrexate; Osteosarcoma; Pharmaceutical Preparations; Pyrazines; RNA, Viral; SARS-CoV-2	2022